Hanna-Maija Kuusisto

Keyphrases

1. Multiple Sclerosis 100%
2. Multiple Sclerosis Treatment 97%
3. Finland 97%
4. Disease-modifying Therapy 91%
5. Healthcare Professionals 60%
6. Shared Decision Making 58%
7. Healthcare 55%
8. Digital Services 51%
9. Do-not-resuscitate Orders 51%
10. Healthcare Workers' Perceptions 51%
11. Health Decision-making 51%
12. Social Care 36%
13. Patient Safety Incident 36%
14. Patient-reported Data 32%
15. Older Adults 31%
16. Healthcare Decisions 31%
17. Alemtuzumab 30%
18. Natalizumab 30%
19. Tumefactive multiple Sclerosis 30%
20. Teriflunomide 30%
21. Human Resources 25%
22. Propensity Score Matching Study 25%
23. Teleneurology 25%
24. Scoping Review Protocol 25%
25. Subjective Rationality 25%
26. Treatment Safety 25%
27. Initial Treatment Strategy 25%
28. Information Quality 25%
29. Clinical Outcomes 25%
30. COVID-19 Pandemic 25%
31. National Cohort Study 25%
32. Neurologist 25%
33. Information Provision 25%
34. Cladribine Tablets 25%
35. Medication Adherence 25%
36. Confidence Interval 25%
37. Health Technology 25%
38. E-health 25%
39. Real-world Clinical Outcomes 25%
40. John Cunningham Virus 25%
41. Vaccination 25%
42. Central Hospitals 25%
43. Chronic Disease 25%
44. MS Patients 25%
45. Professional Opinion 25%
46. Elderly People 25%
47. Professionals' Reactions 25%
48. Nationwide Registry 25%
49. Non-reporting 25%
50. Non-adherence 25%